Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat

被引:0
|
作者
J. Kuhmonen
A. Haapalinna
J. Sivenius
机构
[1] Department of Neurology,
[2] University of Kuopio,undefined
[3] Kuopio,undefined
[4] ,undefined
[5] Orion Corporation,undefined
[6] Orion Pharma,undefined
[7] Turku,undefined
[8] and,undefined
[9] Department of Neurology,undefined
[10] University of Kuopio and Brain Research and Rehabilititation Center "Neuron",undefined
[11] Kuopio,undefined
[12] Finland,undefined
来源
关键词
Keywords:α2-Adrenoceptor agonist; focal cerebral ischemia; neuroprotection; rat.;
D O I
暂无
中图分类号
学科分类号
摘要
Increased sympathetic tone is a consequence of cerebral ischemia. Although the role of catecholamines in ischemic damage is still unclear, in some experimental ischemia models α2-adrenergic agonism has proved to be neuroprotective. In the present work we have compared the effects of transient and permanent middle cerebral artery occlusion (MCAO) on the infarct volume, and, also, examined whether a selective α2-adrenergic receptor agonist, dexmedetomidine (9 μg/kg or 15 μg/kg i.v.), is able to reduce ischemic damage after transient or permanent MCAO in rats. Permanent MCAO led to a significantly larger infarct volume than transient occlusion (p < 0.05). The rats receiving the higher dose of dexmedetomidine were detectected to have smaller (statistically non-significant) infarct volume in the cortex (30.9%) and in the striatum (20.3%) after transient occlusion. Additionally, dexmedetomidine caused significant variations in the physiological parameters.
引用
收藏
页码:261 / 271
页数:10
相关论文
共 50 条
  • [31] Reperfusion hemorrhage after middle cerebral artery occlusion in the rat
    Fagan, SC
    Garcia, JH
    NEUROLOGY, 1996, 46 (02) : 2092 - 2092
  • [32] Proteomic changes in retina after transient middle cerebral artery occlusion
    Ansar, Saema
    Cehofski, Lasse Joergensen
    Blixt, Frank W.
    Haanes, Kristian Agmund
    Fedulov, Vadim
    Honore, Bent
    Edvinsson, Lars
    Warfvinge, Karin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [33] Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat
    Peters, O
    Back, T
    Lindauer, U
    Busch, C
    Megow, D
    Dreier, J
    Dirnagl, U
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (02): : 196 - 205
  • [34] Clinical and pathological responses to permanent middle cerebral artery occlusion in the Wistar rat
    Hagiwara, M
    Pantoni, L
    Gutierrez, JA
    Liu, KK
    Inamura, K
    Katayama, Y
    Terashi, A
    Garcia, JH
    BRAIN PATHOLOGY, 2000, 10 (04) : 561 - 561
  • [35] Dendritic cells are present in the ischemic hemispheres after permanent middle cerebral artery occlusion in the rat.
    Kostulas, N
    Li, HL
    Giedraitas, L
    Kastulas, V
    Link, H
    STROKE, 2000, 31 (11) : 2863 - 2863
  • [36] Effects of serotonin on cerebral circulation after middle cerebral artery occlusion
    Muhonen, MG
    Robertson, SC
    Gerdes, JS
    Loftus, CM
    JOURNAL OF NEUROSURGERY, 1997, 87 (02) : 301 - 306
  • [37] Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion
    Zhao, Heng
    Wang, Jade Q.
    Shimohata, Takayoshi
    Sun, Guohua
    Yenari, Midori A.
    Sapolsky, Robert M.
    Steinberg, Gary K.
    JOURNAL OF NEUROSURGERY, 2007, 107 (03) : 636 - 641
  • [38] MINOCYCLINE IMPROVES CEREBRAL EDEMA AFTER TRANSIENT MIDDLE CEREBRAL ARTERY OCCLUSION IN RATS
    Elkordy, Alaa
    Faheem, Heba
    Elhfnawy, Ahmed
    COMMUNICATIONS IN MATHEMATICAL BIOLOGY AND NEUROSCIENCE, 2024,
  • [39] EFFECTS OF NIMODIPINE ON INFARCT SIZE AND CEREBRAL ACIDOSIS AFTER MIDDLE CEREBRAL-ARTERY OCCLUSION IN THE RAT
    BIELENBERG, GW
    BURNIOL, M
    ROSEN, R
    KLAUS, W
    STROKE, 1990, 21 (12) : 90 - 92
  • [40] Therapeutic time window of Ad-GDNF after transient middle cerebral artery occlusion in rat
    Zhang, WR
    Sato, K
    Iwai, M
    Nagano, I
    Abe, K
    MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA, 2003, 1252 : 265 - 273